Crossvault Capital Management LLC cut its position in UnitedHealth Group Incorporated (NYSE:UNH) by 0.3% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 36,935 shares of the healthcare conglomerate’s stock after selling 100 shares during the period. UnitedHealth Group makes up 4.1% of Crossvault Capital Management LLC’s investment portfolio, making the stock its 3rd largest position. Crossvault Capital Management LLC’s holdings in UnitedHealth Group were worth $6,848,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of the company. Jackson Grant Investment Advisers Inc. boosted its position in UnitedHealth Group by 0.4% in the first quarter. Jackson Grant Investment Advisers Inc. now owns 1,097 shares of the healthcare conglomerate’s stock worth $180,000 after buying an additional 4 shares during the period. Adirondack Trust Co. boosted its position in UnitedHealth Group by 0.5% in the first quarter. Adirondack Trust Co. now owns 990 shares of the healthcare conglomerate’s stock worth $162,000 after buying an additional 5 shares during the period. RB Capital Management LLC boosted its position in UnitedHealth Group by 0.4% in the second quarter. RB Capital Management LLC now owns 1,732 shares of the healthcare conglomerate’s stock worth $321,000 after buying an additional 7 shares during the period. Paradigm Financial Advisors LLC boosted its position in UnitedHealth Group by 0.4% in the first quarter. Paradigm Financial Advisors LLC now owns 2,761 shares of the healthcare conglomerate’s stock worth $452,000 after buying an additional 11 shares during the period. Finally, Parkside Financial Bank & Trust boosted its position in UnitedHealth Group by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock worth $140,000 after buying an additional 12 shares during the period. 86.37% of the stock is owned by hedge funds and other institutional investors.

Shares of UnitedHealth Group Incorporated (UNH) traded up 0.23% during mid-day trading on Friday, hitting $193.02. 2,210,720 shares of the stock traded hands. The firm’s 50-day moving average is $189.36 and its 200-day moving average is $174.75. The stock has a market cap of $186.62 billion, a price-to-earnings ratio of 23.19 and a beta of 0.64. UnitedHealth Group Incorporated has a 52 week low of $132.39 and a 52 week high of $196.04.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The firm had revenue of $50.05 billion for the quarter, compared to analysts’ expectations of $49.97 billion. During the same period in the previous year, the firm earned $1.96 earnings per share. The business’s revenue was up 7.7% compared to the same quarter last year. On average, analysts forecast that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: “UnitedHealth Group Incorporated (NYSE:UNH) is Crossvault Capital Management LLC’s 3rd Largest Position” was first posted by Daily Political and is the sole property of of Daily Political. If you are viewing this story on another site, it was copied illegally and reposted in violation of international copyright and trademark laws. The correct version of this story can be viewed at https://www.dailypolitical.com/2017/08/12/unitedhealth-group-incorporated-nyseunh-is-crossvault-capital-management-llcs-3rd-largest-position.html.

A number of research firms have recently commented on UNH. UBS AG reissued a “buy” rating and issued a $194.00 target price (up previously from $193.00) on shares of UnitedHealth Group in a report on Saturday, April 22nd. Cowen and Company reissued an “outperform” rating and issued a $220.00 target price (up previously from $175.00) on shares of UnitedHealth Group in a report on Friday. Cantor Fitzgerald reissued an “overweight” rating and issued a $205.00 target price (up previously from $200.00) on shares of UnitedHealth Group in a report on Saturday, April 22nd. Sanford C. Bernstein reissued an “outperform” rating and issued a $190.00 target price on shares of UnitedHealth Group in a report on Monday, July 10th. Finally, Credit Suisse Group reaffirmed an “outperform” rating and issued a $200.00 price objective (up previously from $195.00) on shares of UnitedHealth Group in a research note on Thursday, July 13th. One equities research analyst has rated the stock with a hold rating and twenty-four have issued a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $202.20.

In related news, Director William C. Ballard, Jr. sold 5,000 shares of the company’s stock in a transaction on Thursday, August 3rd. The stock was sold at an average price of $193.98, for a total value of $969,900.00. Following the sale, the director now directly owns 76,058 shares of the company’s stock, valued at $14,753,730.84. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Gail R. Wilensky sold 5,540 shares of the company’s stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $178.74, for a total value of $990,219.60. Following the completion of the sale, the director now directly owns 60,516 shares in the company, valued at $10,816,629.84. The disclosure for this sale can be found here. Insiders have sold 15,540 shares of company stock worth $2,873,320 over the last three months. Insiders own 0.89% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.